nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticagrelor—CYP3A4—prostate cancer	0.228	1	CbGaD
Ticagrelor—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0572	0.112	CbGbCtD
Ticagrelor—ABCB1—Estramustine—prostate cancer	0.0466	0.0915	CbGbCtD
Ticagrelor—ABCB1—Cabazitaxel—prostate cancer	0.0307	0.0603	CbGbCtD
Ticagrelor—CYP3A4—Bicalutamide—prostate cancer	0.0301	0.059	CbGbCtD
Ticagrelor—ABCB1—Estrone—prostate cancer	0.0301	0.059	CbGbCtD
Ticagrelor—CYP3A4—Estramustine—prostate cancer	0.0279	0.0548	CbGbCtD
Ticagrelor—ABCB1—Ethinyl Estradiol—prostate cancer	0.0268	0.0526	CbGbCtD
Ticagrelor—CYP3A4—Abiraterone—prostate cancer	0.0249	0.0489	CbGbCtD
Ticagrelor—CYP3A4—Flutamide—prostate cancer	0.0249	0.0489	CbGbCtD
Ticagrelor—ABCB1—Conjugated Estrogens—prostate cancer	0.0197	0.0386	CbGbCtD
Ticagrelor—CYP3A4—Cabazitaxel—prostate cancer	0.0184	0.0361	CbGbCtD
Ticagrelor—CYP3A4—Estrone—prostate cancer	0.018	0.0353	CbGbCtD
Ticagrelor—ABCB1—Mitoxantrone—prostate cancer	0.0179	0.0351	CbGbCtD
Ticagrelor—ABCB1—Estradiol—prostate cancer	0.0173	0.0339	CbGbCtD
Ticagrelor—CYP3A4—Ethinyl Estradiol—prostate cancer	0.016	0.0315	CbGbCtD
Ticagrelor—ABCB1—Prednisone—prostate cancer	0.0148	0.0291	CbGbCtD
Ticagrelor—CYP3A4—Conjugated Estrogens—prostate cancer	0.0118	0.0231	CbGbCtD
Ticagrelor—ABCB1—Etoposide—prostate cancer	0.0113	0.0221	CbGbCtD
Ticagrelor—CYP3A4—Mitoxantrone—prostate cancer	0.0107	0.021	CbGbCtD
Ticagrelor—CYP3A4—Estradiol—prostate cancer	0.0103	0.0203	CbGbCtD
Ticagrelor—ABCB1—Docetaxel—prostate cancer	0.0103	0.0202	CbGbCtD
Ticagrelor—CYP3A4—Prednisone—prostate cancer	0.00889	0.0174	CbGbCtD
Ticagrelor—ABCB1—Doxorubicin—prostate cancer	0.00769	0.0151	CbGbCtD
Ticagrelor—CYP3A4—Etoposide—prostate cancer	0.00675	0.0132	CbGbCtD
Ticagrelor—CYP3A4—Docetaxel—prostate cancer	0.00618	0.0121	CbGbCtD
Ticagrelor—CYP3A4—Doxorubicin—prostate cancer	0.00461	0.00904	CbGbCtD
Ticagrelor—P2RY12—prostate gland—prostate cancer	0.00263	0.336	CbGeAlD
Ticagrelor—P2RY12—epithelium—prostate cancer	0.00194	0.247	CbGeAlD
Ticagrelor—CYP3A4—urine—prostate cancer	0.00128	0.163	CbGeAlD
Ticagrelor—ABCB1—prostate gland—prostate cancer	0.000324	0.0413	CbGeAlD
Ticagrelor—CYP3A4—renal system—prostate cancer	0.000312	0.0398	CbGeAlD
Ticagrelor—ABCB1—seminal vesicle—prostate cancer	0.000274	0.0349	CbGeAlD
Ticagrelor—ABCB1—epithelium—prostate cancer	0.000238	0.0304	CbGeAlD
Ticagrelor—ABCB1—renal system—prostate cancer	0.000221	0.0282	CbGeAlD
Ticagrelor—ABCB1—urethra—prostate cancer	0.000217	0.0277	CbGeAlD
Ticagrelor—ABCB1—bone marrow—prostate cancer	0.000167	0.0213	CbGeAlD
Ticagrelor—ABCB1—testis—prostate cancer	0.000143	0.0182	CbGeAlD
Ticagrelor—ABCB1—lymph node—prostate cancer	0.000103	0.0132	CbGeAlD
Ticagrelor—Headache—Conjugated Estrogens—prostate cancer	9.62e-05	0.000507	CcSEcCtD
Ticagrelor—Gastritis—Epirubicin—prostate cancer	9.61e-05	0.000507	CcSEcCtD
Ticagrelor—Haemorrhage—Prednisone—prostate cancer	9.61e-05	0.000507	CcSEcCtD
Ticagrelor—Confusional state—Etoposide—prostate cancer	9.6e-05	0.000506	CcSEcCtD
Ticagrelor—Mental disorder—Capecitabine—prostate cancer	9.45e-05	0.000498	CcSEcCtD
Ticagrelor—Connective tissue disorder—Prednisone—prostate cancer	9.44e-05	0.000498	CcSEcCtD
Ticagrelor—Feeling abnormal—Mitoxantrone—prostate cancer	9.44e-05	0.000497	CcSEcCtD
Ticagrelor—Blood creatinine increased—Doxorubicin—prostate cancer	9.42e-05	0.000496	CcSEcCtD
Ticagrelor—Malnutrition—Capecitabine—prostate cancer	9.39e-05	0.000495	CcSEcCtD
Ticagrelor—Back pain—Docetaxel—prostate cancer	9.38e-05	0.000495	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Mitoxantrone—prostate cancer	9.36e-05	0.000494	CcSEcCtD
Ticagrelor—Skin disorder—Etoposide—prostate cancer	9.25e-05	0.000488	CcSEcCtD
Ticagrelor—Nausea—Goserelin—prostate cancer	9.21e-05	0.000485	CcSEcCtD
Ticagrelor—Nausea—Conjugated Estrogens—prostate cancer	9.12e-05	0.000481	CcSEcCtD
Ticagrelor—Back pain—Capecitabine—prostate cancer	9.08e-05	0.000479	CcSEcCtD
Ticagrelor—Breast disorder—Doxorubicin—prostate cancer	9.08e-05	0.000479	CcSEcCtD
Ticagrelor—Hypersensitivity—Estradiol—prostate cancer	9.05e-05	0.000477	CcSEcCtD
Ticagrelor—Abdominal pain—Mitoxantrone—prostate cancer	9.05e-05	0.000477	CcSEcCtD
Ticagrelor—Body temperature increased—Mitoxantrone—prostate cancer	9.05e-05	0.000477	CcSEcCtD
Ticagrelor—Eye disorder—Prednisone—prostate cancer	8.98e-05	0.000473	CcSEcCtD
Ticagrelor—Hypotension—Etoposide—prostate cancer	8.9e-05	0.000469	CcSEcCtD
Ticagrelor—Gastritis—Doxorubicin—prostate cancer	8.9e-05	0.000469	CcSEcCtD
Ticagrelor—Asthenia—Estradiol—prostate cancer	8.82e-05	0.000465	CcSEcCtD
Ticagrelor—Angiopathy—Prednisone—prostate cancer	8.72e-05	0.00046	CcSEcCtD
Ticagrelor—Syncope—Docetaxel—prostate cancer	8.7e-05	0.000459	CcSEcCtD
Ticagrelor—Pruritus—Estradiol—prostate cancer	8.69e-05	0.000458	CcSEcCtD
Ticagrelor—Immune system disorder—Prednisone—prostate cancer	8.68e-05	0.000458	CcSEcCtD
Ticagrelor—Paraesthesia—Etoposide—prostate cancer	8.55e-05	0.000451	CcSEcCtD
Ticagrelor—Loss of consciousness—Docetaxel—prostate cancer	8.52e-05	0.000449	CcSEcCtD
Ticagrelor—Dyspnoea—Etoposide—prostate cancer	8.49e-05	0.000448	CcSEcCtD
Ticagrelor—Cough—Docetaxel—prostate cancer	8.46e-05	0.000446	CcSEcCtD
Ticagrelor—Vertigo—Capecitabine—prostate cancer	8.44e-05	0.000445	CcSEcCtD
Ticagrelor—Hypersensitivity—Mitoxantrone—prostate cancer	8.44e-05	0.000445	CcSEcCtD
Ticagrelor—Syncope—Capecitabine—prostate cancer	8.42e-05	0.000444	CcSEcCtD
Ticagrelor—Mental disorder—Prednisone—prostate cancer	8.42e-05	0.000444	CcSEcCtD
Ticagrelor—Diarrhoea—Estradiol—prostate cancer	8.41e-05	0.000443	CcSEcCtD
Ticagrelor—Hypertension—Docetaxel—prostate cancer	8.37e-05	0.000441	CcSEcCtD
Ticagrelor—Malnutrition—Prednisone—prostate cancer	8.36e-05	0.000441	CcSEcCtD
Ticagrelor—Chest pain—Docetaxel—prostate cancer	8.26e-05	0.000435	CcSEcCtD
Ticagrelor—Loss of consciousness—Capecitabine—prostate cancer	8.25e-05	0.000435	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Etoposide—prostate cancer	8.22e-05	0.000434	CcSEcCtD
Ticagrelor—Asthenia—Mitoxantrone—prostate cancer	8.22e-05	0.000433	CcSEcCtD
Ticagrelor—Fatigue—Etoposide—prostate cancer	8.21e-05	0.000433	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	8.2e-05	0.000432	CcSEcCtD
Ticagrelor—Cough—Capecitabine—prostate cancer	8.19e-05	0.000432	CcSEcCtD
Ticagrelor—Constipation—Etoposide—prostate cancer	8.15e-05	0.000429	CcSEcCtD
Ticagrelor—Dizziness—Estradiol—prostate cancer	8.13e-05	0.000428	CcSEcCtD
Ticagrelor—Hypertension—Capecitabine—prostate cancer	8.11e-05	0.000427	CcSEcCtD
Ticagrelor—Chest pain—Capecitabine—prostate cancer	7.99e-05	0.000421	CcSEcCtD
Ticagrelor—Haematuria—Epirubicin—prostate cancer	7.98e-05	0.000421	CcSEcCtD
Ticagrelor—Confusional state—Docetaxel—prostate cancer	7.98e-05	0.000421	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	7.94e-05	0.000419	CcSEcCtD
Ticagrelor—Epistaxis—Epirubicin—prostate cancer	7.9e-05	0.000416	CcSEcCtD
Ticagrelor—Feeling abnormal—Etoposide—prostate cancer	7.85e-05	0.000414	CcSEcCtD
Ticagrelor—Diarrhoea—Mitoxantrone—prostate cancer	7.83e-05	0.000413	CcSEcCtD
Ticagrelor—Vomiting—Estradiol—prostate cancer	7.81e-05	0.000412	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Etoposide—prostate cancer	7.79e-05	0.000411	CcSEcCtD
Ticagrelor—Shock—Docetaxel—prostate cancer	7.79e-05	0.000411	CcSEcCtD
Ticagrelor—Nervous system disorder—Docetaxel—prostate cancer	7.76e-05	0.000409	CcSEcCtD
Ticagrelor—Rash—Estradiol—prostate cancer	7.75e-05	0.000409	CcSEcCtD
Ticagrelor—Dermatitis—Estradiol—prostate cancer	7.74e-05	0.000408	CcSEcCtD
Ticagrelor—Confusional state—Capecitabine—prostate cancer	7.73e-05	0.000407	CcSEcCtD
Ticagrelor—Headache—Estradiol—prostate cancer	7.7e-05	0.000406	CcSEcCtD
Ticagrelor—Skin disorder—Docetaxel—prostate cancer	7.69e-05	0.000405	CcSEcCtD
Ticagrelor—Bradycardia—Epirubicin—prostate cancer	7.65e-05	0.000403	CcSEcCtD
Ticagrelor—Angioedema—Prednisone—prostate cancer	7.64e-05	0.000403	CcSEcCtD
Ticagrelor—Haemoglobin—Epirubicin—prostate cancer	7.55e-05	0.000398	CcSEcCtD
Ticagrelor—Shock—Capecitabine—prostate cancer	7.54e-05	0.000398	CcSEcCtD
Ticagrelor—Abdominal pain—Etoposide—prostate cancer	7.53e-05	0.000397	CcSEcCtD
Ticagrelor—Body temperature increased—Etoposide—prostate cancer	7.53e-05	0.000397	CcSEcCtD
Ticagrelor—Nervous system disorder—Capecitabine—prostate cancer	7.52e-05	0.000396	CcSEcCtD
Ticagrelor—Vertigo—Prednisone—prostate cancer	7.52e-05	0.000396	CcSEcCtD
Ticagrelor—Haemorrhage—Epirubicin—prostate cancer	7.52e-05	0.000396	CcSEcCtD
Ticagrelor—Syncope—Prednisone—prostate cancer	7.5e-05	0.000395	CcSEcCtD
Ticagrelor—Skin disorder—Capecitabine—prostate cancer	7.44e-05	0.000392	CcSEcCtD
Ticagrelor—Urinary tract disorder—Epirubicin—prostate cancer	7.42e-05	0.000391	CcSEcCtD
Ticagrelor—Oedema peripheral—Epirubicin—prostate cancer	7.4e-05	0.00039	CcSEcCtD
Ticagrelor—Hypotension—Docetaxel—prostate cancer	7.4e-05	0.00039	CcSEcCtD
Ticagrelor—Haematuria—Doxorubicin—prostate cancer	7.39e-05	0.000389	CcSEcCtD
Ticagrelor—Connective tissue disorder—Epirubicin—prostate cancer	7.38e-05	0.000389	CcSEcCtD
Ticagrelor—Urethral disorder—Epirubicin—prostate cancer	7.37e-05	0.000388	CcSEcCtD
Ticagrelor—Loss of consciousness—Prednisone—prostate cancer	7.35e-05	0.000388	CcSEcCtD
Ticagrelor—Epistaxis—Doxorubicin—prostate cancer	7.31e-05	0.000385	CcSEcCtD
Ticagrelor—Nausea—Estradiol—prostate cancer	7.3e-05	0.000385	CcSEcCtD
Ticagrelor—Vomiting—Mitoxantrone—prostate cancer	7.28e-05	0.000384	CcSEcCtD
Ticagrelor—Hypertension—Prednisone—prostate cancer	7.22e-05	0.000381	CcSEcCtD
Ticagrelor—Rash—Mitoxantrone—prostate cancer	7.22e-05	0.000381	CcSEcCtD
Ticagrelor—Dermatitis—Mitoxantrone—prostate cancer	7.21e-05	0.00038	CcSEcCtD
Ticagrelor—Headache—Mitoxantrone—prostate cancer	7.17e-05	0.000378	CcSEcCtD
Ticagrelor—Hypotension—Capecitabine—prostate cancer	7.16e-05	0.000378	CcSEcCtD
Ticagrelor—Paraesthesia—Docetaxel—prostate cancer	7.11e-05	0.000375	CcSEcCtD
Ticagrelor—Bradycardia—Doxorubicin—prostate cancer	7.08e-05	0.000373	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	7.07e-05	0.000373	CcSEcCtD
Ticagrelor—Dyspnoea—Docetaxel—prostate cancer	7.06e-05	0.000372	CcSEcCtD
Ticagrelor—Eye disorder—Epirubicin—prostate cancer	7.02e-05	0.00037	CcSEcCtD
Ticagrelor—Hypersensitivity—Etoposide—prostate cancer	7.02e-05	0.00037	CcSEcCtD
Ticagrelor—Haemoglobin—Doxorubicin—prostate cancer	6.99e-05	0.000368	CcSEcCtD
Ticagrelor—Cardiac disorder—Epirubicin—prostate cancer	6.97e-05	0.000368	CcSEcCtD
Ticagrelor—Dyspepsia—Docetaxel—prostate cancer	6.97e-05	0.000367	CcSEcCtD
Ticagrelor—Haemorrhage—Doxorubicin—prostate cancer	6.95e-05	0.000367	CcSEcCtD
Ticagrelor—Paraesthesia—Capecitabine—prostate cancer	6.88e-05	0.000363	CcSEcCtD
Ticagrelor—Urinary tract disorder—Doxorubicin—prostate cancer	6.87e-05	0.000362	CcSEcCtD
Ticagrelor—Oedema peripheral—Doxorubicin—prostate cancer	6.85e-05	0.000361	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Docetaxel—prostate cancer	6.83e-05	0.00036	CcSEcCtD
Ticagrelor—Asthenia—Etoposide—prostate cancer	6.83e-05	0.00036	CcSEcCtD
Ticagrelor—Connective tissue disorder—Doxorubicin—prostate cancer	6.83e-05	0.00036	CcSEcCtD
Ticagrelor—Dyspnoea—Capecitabine—prostate cancer	6.83e-05	0.00036	CcSEcCtD
Ticagrelor—Fatigue—Docetaxel—prostate cancer	6.82e-05	0.00036	CcSEcCtD
Ticagrelor—Angiopathy—Epirubicin—prostate cancer	6.82e-05	0.000359	CcSEcCtD
Ticagrelor—Urethral disorder—Doxorubicin—prostate cancer	6.82e-05	0.000359	CcSEcCtD
Ticagrelor—Nausea—Mitoxantrone—prostate cancer	6.8e-05	0.000359	CcSEcCtD
Ticagrelor—Immune system disorder—Epirubicin—prostate cancer	6.79e-05	0.000358	CcSEcCtD
Ticagrelor—Mediastinal disorder—Epirubicin—prostate cancer	6.77e-05	0.000357	CcSEcCtD
Ticagrelor—Constipation—Docetaxel—prostate cancer	6.77e-05	0.000357	CcSEcCtD
Ticagrelor—Dyspepsia—Capecitabine—prostate cancer	6.75e-05	0.000356	CcSEcCtD
Ticagrelor—Pruritus—Etoposide—prostate cancer	6.74e-05	0.000355	CcSEcCtD
Ticagrelor—Shock—Prednisone—prostate cancer	6.72e-05	0.000354	CcSEcCtD
Ticagrelor—Nervous system disorder—Prednisone—prostate cancer	6.69e-05	0.000353	CcSEcCtD
Ticagrelor—Skin disorder—Prednisone—prostate cancer	6.63e-05	0.00035	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Capecitabine—prostate cancer	6.62e-05	0.000349	CcSEcCtD
Ticagrelor—Fatigue—Capecitabine—prostate cancer	6.61e-05	0.000348	CcSEcCtD
Ticagrelor—Mental disorder—Epirubicin—prostate cancer	6.58e-05	0.000347	CcSEcCtD
Ticagrelor—Constipation—Capecitabine—prostate cancer	6.55e-05	0.000346	CcSEcCtD
Ticagrelor—Malnutrition—Epirubicin—prostate cancer	6.54e-05	0.000345	CcSEcCtD
Ticagrelor—Feeling abnormal—Docetaxel—prostate cancer	6.52e-05	0.000344	CcSEcCtD
Ticagrelor—Diarrhoea—Etoposide—prostate cancer	6.52e-05	0.000344	CcSEcCtD
Ticagrelor—Eye disorder—Doxorubicin—prostate cancer	6.5e-05	0.000343	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Docetaxel—prostate cancer	6.47e-05	0.000341	CcSEcCtD
Ticagrelor—Cardiac disorder—Doxorubicin—prostate cancer	6.45e-05	0.00034	CcSEcCtD
Ticagrelor—Back pain—Epirubicin—prostate cancer	6.33e-05	0.000334	CcSEcCtD
Ticagrelor—Feeling abnormal—Capecitabine—prostate cancer	6.32e-05	0.000333	CcSEcCtD
Ticagrelor—Angiopathy—Doxorubicin—prostate cancer	6.31e-05	0.000333	CcSEcCtD
Ticagrelor—Dizziness—Etoposide—prostate cancer	6.3e-05	0.000332	CcSEcCtD
Ticagrelor—Immune system disorder—Doxorubicin—prostate cancer	6.28e-05	0.000331	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Capecitabine—prostate cancer	6.27e-05	0.00033	CcSEcCtD
Ticagrelor—Mediastinal disorder—Doxorubicin—prostate cancer	6.27e-05	0.00033	CcSEcCtD
Ticagrelor—Body temperature increased—Docetaxel—prostate cancer	6.26e-05	0.00033	CcSEcCtD
Ticagrelor—Abdominal pain—Docetaxel—prostate cancer	6.26e-05	0.00033	CcSEcCtD
Ticagrelor—Paraesthesia—Prednisone—prostate cancer	6.13e-05	0.000323	CcSEcCtD
Ticagrelor—Mental disorder—Doxorubicin—prostate cancer	6.09e-05	0.000321	CcSEcCtD
Ticagrelor—Abdominal pain—Capecitabine—prostate cancer	6.06e-05	0.000319	CcSEcCtD
Ticagrelor—Body temperature increased—Capecitabine—prostate cancer	6.06e-05	0.000319	CcSEcCtD
Ticagrelor—Vomiting—Etoposide—prostate cancer	6.06e-05	0.000319	CcSEcCtD
Ticagrelor—Malnutrition—Doxorubicin—prostate cancer	6.05e-05	0.000319	CcSEcCtD
Ticagrelor—Dyspepsia—Prednisone—prostate cancer	6.01e-05	0.000317	CcSEcCtD
Ticagrelor—Rash—Etoposide—prostate cancer	6.01e-05	0.000317	CcSEcCtD
Ticagrelor—Dermatitis—Etoposide—prostate cancer	6e-05	0.000316	CcSEcCtD
Ticagrelor—Headache—Etoposide—prostate cancer	5.97e-05	0.000315	CcSEcCtD
Ticagrelor—Fatigue—Prednisone—prostate cancer	5.89e-05	0.00031	CcSEcCtD
Ticagrelor—Vertigo—Epirubicin—prostate cancer	5.88e-05	0.00031	CcSEcCtD
Ticagrelor—Syncope—Epirubicin—prostate cancer	5.87e-05	0.000309	CcSEcCtD
Ticagrelor—Back pain—Doxorubicin—prostate cancer	5.86e-05	0.000309	CcSEcCtD
Ticagrelor—Constipation—Prednisone—prostate cancer	5.84e-05	0.000308	CcSEcCtD
Ticagrelor—Hypersensitivity—Docetaxel—prostate cancer	5.83e-05	0.000307	CcSEcCtD
Ticagrelor—Loss of consciousness—Epirubicin—prostate cancer	5.75e-05	0.000303	CcSEcCtD
Ticagrelor—Cough—Epirubicin—prostate cancer	5.71e-05	0.000301	CcSEcCtD
Ticagrelor—Asthenia—Docetaxel—prostate cancer	5.68e-05	0.000299	CcSEcCtD
Ticagrelor—Nausea—Etoposide—prostate cancer	5.66e-05	0.000298	CcSEcCtD
Ticagrelor—Hypertension—Epirubicin—prostate cancer	5.65e-05	0.000298	CcSEcCtD
Ticagrelor—Hypersensitivity—Capecitabine—prostate cancer	5.65e-05	0.000298	CcSEcCtD
Ticagrelor—Feeling abnormal—Prednisone—prostate cancer	5.63e-05	0.000297	CcSEcCtD
Ticagrelor—Pruritus—Docetaxel—prostate cancer	5.6e-05	0.000295	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Prednisone—prostate cancer	5.58e-05	0.000294	CcSEcCtD
Ticagrelor—Chest pain—Epirubicin—prostate cancer	5.57e-05	0.000294	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	5.53e-05	0.000292	CcSEcCtD
Ticagrelor—Asthenia—Capecitabine—prostate cancer	5.5e-05	0.00029	CcSEcCtD
Ticagrelor—Vertigo—Doxorubicin—prostate cancer	5.44e-05	0.000287	CcSEcCtD
Ticagrelor—Syncope—Doxorubicin—prostate cancer	5.43e-05	0.000286	CcSEcCtD
Ticagrelor—Pruritus—Capecitabine—prostate cancer	5.42e-05	0.000286	CcSEcCtD
Ticagrelor—Diarrhoea—Docetaxel—prostate cancer	5.42e-05	0.000286	CcSEcCtD
Ticagrelor—Abdominal pain—Prednisone—prostate cancer	5.4e-05	0.000285	CcSEcCtD
Ticagrelor—Body temperature increased—Prednisone—prostate cancer	5.4e-05	0.000285	CcSEcCtD
Ticagrelor—Confusional state—Epirubicin—prostate cancer	5.38e-05	0.000284	CcSEcCtD
Ticagrelor—Loss of consciousness—Doxorubicin—prostate cancer	5.32e-05	0.00028	CcSEcCtD
Ticagrelor—Cough—Doxorubicin—prostate cancer	5.28e-05	0.000278	CcSEcCtD
Ticagrelor—Shock—Epirubicin—prostate cancer	5.25e-05	0.000277	CcSEcCtD
Ticagrelor—Diarrhoea—Capecitabine—prostate cancer	5.24e-05	0.000276	CcSEcCtD
Ticagrelor—Nervous system disorder—Epirubicin—prostate cancer	5.24e-05	0.000276	CcSEcCtD
Ticagrelor—Dizziness—Docetaxel—prostate cancer	5.23e-05	0.000276	CcSEcCtD
Ticagrelor—Hypertension—Doxorubicin—prostate cancer	5.23e-05	0.000276	CcSEcCtD
Ticagrelor—Skin disorder—Epirubicin—prostate cancer	5.19e-05	0.000273	CcSEcCtD
Ticagrelor—Chest pain—Doxorubicin—prostate cancer	5.15e-05	0.000272	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	5.12e-05	0.00027	CcSEcCtD
Ticagrelor—Dizziness—Capecitabine—prostate cancer	5.07e-05	0.000267	CcSEcCtD
Ticagrelor—Vomiting—Docetaxel—prostate cancer	5.03e-05	0.000265	CcSEcCtD
Ticagrelor—Hypersensitivity—Prednisone—prostate cancer	5.03e-05	0.000265	CcSEcCtD
Ticagrelor—Rash—Docetaxel—prostate cancer	4.99e-05	0.000263	CcSEcCtD
Ticagrelor—Hypotension—Epirubicin—prostate cancer	4.99e-05	0.000263	CcSEcCtD
Ticagrelor—Dermatitis—Docetaxel—prostate cancer	4.99e-05	0.000263	CcSEcCtD
Ticagrelor—Confusional state—Doxorubicin—prostate cancer	4.98e-05	0.000263	CcSEcCtD
Ticagrelor—Headache—Docetaxel—prostate cancer	4.96e-05	0.000261	CcSEcCtD
Ticagrelor—Asthenia—Prednisone—prostate cancer	4.9e-05	0.000258	CcSEcCtD
Ticagrelor—Vomiting—Capecitabine—prostate cancer	4.87e-05	0.000257	CcSEcCtD
Ticagrelor—Shock—Doxorubicin—prostate cancer	4.86e-05	0.000256	CcSEcCtD
Ticagrelor—Nervous system disorder—Doxorubicin—prostate cancer	4.84e-05	0.000255	CcSEcCtD
Ticagrelor—Rash—Capecitabine—prostate cancer	4.83e-05	0.000255	CcSEcCtD
Ticagrelor—Pruritus—Prednisone—prostate cancer	4.83e-05	0.000255	CcSEcCtD
Ticagrelor—Dermatitis—Capecitabine—prostate cancer	4.83e-05	0.000255	CcSEcCtD
Ticagrelor—Headache—Capecitabine—prostate cancer	4.8e-05	0.000253	CcSEcCtD
Ticagrelor—Skin disorder—Doxorubicin—prostate cancer	4.8e-05	0.000253	CcSEcCtD
Ticagrelor—Paraesthesia—Epirubicin—prostate cancer	4.79e-05	0.000253	CcSEcCtD
Ticagrelor—Dyspnoea—Epirubicin—prostate cancer	4.76e-05	0.000251	CcSEcCtD
Ticagrelor—Nausea—Docetaxel—prostate cancer	4.7e-05	0.000248	CcSEcCtD
Ticagrelor—Dyspepsia—Epirubicin—prostate cancer	4.7e-05	0.000248	CcSEcCtD
Ticagrelor—Diarrhoea—Prednisone—prostate cancer	4.67e-05	0.000246	CcSEcCtD
Ticagrelor—Hypotension—Doxorubicin—prostate cancer	4.62e-05	0.000243	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Epirubicin—prostate cancer	4.61e-05	0.000243	CcSEcCtD
Ticagrelor—Fatigue—Epirubicin—prostate cancer	4.6e-05	0.000243	CcSEcCtD
Ticagrelor—Constipation—Epirubicin—prostate cancer	4.57e-05	0.000241	CcSEcCtD
Ticagrelor—Nausea—Capecitabine—prostate cancer	4.55e-05	0.00024	CcSEcCtD
Ticagrelor—Dizziness—Prednisone—prostate cancer	4.51e-05	0.000238	CcSEcCtD
Ticagrelor—Paraesthesia—Doxorubicin—prostate cancer	4.44e-05	0.000234	CcSEcCtD
Ticagrelor—Dyspnoea—Doxorubicin—prostate cancer	4.4e-05	0.000232	CcSEcCtD
Ticagrelor—Feeling abnormal—Epirubicin—prostate cancer	4.4e-05	0.000232	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Epirubicin—prostate cancer	4.37e-05	0.00023	CcSEcCtD
Ticagrelor—Dyspepsia—Doxorubicin—prostate cancer	4.35e-05	0.000229	CcSEcCtD
Ticagrelor—Vomiting—Prednisone—prostate cancer	4.34e-05	0.000229	CcSEcCtD
Ticagrelor—Rash—Prednisone—prostate cancer	4.3e-05	0.000227	CcSEcCtD
Ticagrelor—Dermatitis—Prednisone—prostate cancer	4.3e-05	0.000227	CcSEcCtD
Ticagrelor—Headache—Prednisone—prostate cancer	4.28e-05	0.000225	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Doxorubicin—prostate cancer	4.27e-05	0.000225	CcSEcCtD
Ticagrelor—Fatigue—Doxorubicin—prostate cancer	4.26e-05	0.000225	CcSEcCtD
Ticagrelor—Constipation—Doxorubicin—prostate cancer	4.22e-05	0.000223	CcSEcCtD
Ticagrelor—Abdominal pain—Epirubicin—prostate cancer	4.22e-05	0.000223	CcSEcCtD
Ticagrelor—Body temperature increased—Epirubicin—prostate cancer	4.22e-05	0.000223	CcSEcCtD
Ticagrelor—Feeling abnormal—Doxorubicin—prostate cancer	4.07e-05	0.000215	CcSEcCtD
Ticagrelor—Nausea—Prednisone—prostate cancer	4.05e-05	0.000214	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Doxorubicin—prostate cancer	4.04e-05	0.000213	CcSEcCtD
Ticagrelor—Hypersensitivity—Epirubicin—prostate cancer	3.93e-05	0.000207	CcSEcCtD
Ticagrelor—Body temperature increased—Doxorubicin—prostate cancer	3.91e-05	0.000206	CcSEcCtD
Ticagrelor—Abdominal pain—Doxorubicin—prostate cancer	3.91e-05	0.000206	CcSEcCtD
Ticagrelor—Asthenia—Epirubicin—prostate cancer	3.83e-05	0.000202	CcSEcCtD
Ticagrelor—Pruritus—Epirubicin—prostate cancer	3.78e-05	0.000199	CcSEcCtD
Ticagrelor—Diarrhoea—Epirubicin—prostate cancer	3.65e-05	0.000193	CcSEcCtD
Ticagrelor—Hypersensitivity—Doxorubicin—prostate cancer	3.64e-05	0.000192	CcSEcCtD
Ticagrelor—Asthenia—Doxorubicin—prostate cancer	3.54e-05	0.000187	CcSEcCtD
Ticagrelor—Dizziness—Epirubicin—prostate cancer	3.53e-05	0.000186	CcSEcCtD
Ticagrelor—Pruritus—Doxorubicin—prostate cancer	3.5e-05	0.000184	CcSEcCtD
Ticagrelor—Vomiting—Epirubicin—prostate cancer	3.39e-05	0.000179	CcSEcCtD
Ticagrelor—Diarrhoea—Doxorubicin—prostate cancer	3.38e-05	0.000178	CcSEcCtD
Ticagrelor—Rash—Epirubicin—prostate cancer	3.37e-05	0.000177	CcSEcCtD
Ticagrelor—Dermatitis—Epirubicin—prostate cancer	3.36e-05	0.000177	CcSEcCtD
Ticagrelor—Headache—Epirubicin—prostate cancer	3.34e-05	0.000176	CcSEcCtD
Ticagrelor—Dizziness—Doxorubicin—prostate cancer	3.27e-05	0.000172	CcSEcCtD
Ticagrelor—Nausea—Epirubicin—prostate cancer	3.17e-05	0.000167	CcSEcCtD
Ticagrelor—Vomiting—Doxorubicin—prostate cancer	3.14e-05	0.000166	CcSEcCtD
Ticagrelor—Rash—Doxorubicin—prostate cancer	3.11e-05	0.000164	CcSEcCtD
Ticagrelor—Dermatitis—Doxorubicin—prostate cancer	3.11e-05	0.000164	CcSEcCtD
Ticagrelor—Headache—Doxorubicin—prostate cancer	3.09e-05	0.000163	CcSEcCtD
Ticagrelor—Nausea—Doxorubicin—prostate cancer	2.93e-05	0.000155	CcSEcCtD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—prostate cancer	1.94e-05	0.000298	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—KDR—prostate cancer	1.94e-05	0.000298	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—prostate cancer	1.9e-05	0.000291	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—NCOA2—prostate cancer	1.89e-05	0.000291	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—ESR1—prostate cancer	1.89e-05	0.00029	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—TNFRSF21—prostate cancer	1.85e-05	0.000284	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—BAD—prostate cancer	1.85e-05	0.000283	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	1.81e-05	0.000277	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—MTAP—prostate cancer	1.8e-05	0.000276	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP7B1—prostate cancer	1.8e-05	0.000276	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—prostate cancer	1.8e-05	0.000276	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—APC—prostate cancer	1.79e-05	0.000274	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PIK3CG—prostate cancer	1.79e-05	0.000274	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—EGF—prostate cancer	1.77e-05	0.000271	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IRS1—prostate cancer	1.77e-05	0.000271	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—prostate cancer	1.76e-05	0.000271	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SULT1E1—prostate cancer	1.75e-05	0.000269	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SRD5A1—prostate cancer	1.75e-05	0.000269	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CBR1—prostate cancer	1.72e-05	0.000264	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GRHL1—prostate cancer	1.72e-05	0.000264	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—TST—prostate cancer	1.72e-05	0.000264	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ADI1—prostate cancer	1.72e-05	0.000264	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PSAT1—prostate cancer	1.72e-05	0.000264	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CSAD—prostate cancer	1.72e-05	0.000264	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—GSK3B—prostate cancer	1.72e-05	0.000263	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—prostate cancer	1.72e-05	0.000263	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—prostate cancer	1.7e-05	0.000261	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—INS—prostate cancer	1.69e-05	0.00026	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ACSL4—prostate cancer	1.67e-05	0.000257	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—HSD17B3—prostate cancer	1.67e-05	0.000257	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	1.66e-05	0.000255	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CREBBP—prostate cancer	1.66e-05	0.000254	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	1.66e-05	0.000254	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IGF1—prostate cancer	1.64e-05	0.000251	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—EGFR—prostate cancer	1.63e-05	0.00025	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PHGDH—prostate cancer	1.6e-05	0.000246	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—UMPS—prostate cancer	1.6e-05	0.000246	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ARG2—prostate cancer	1.6e-05	0.000246	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—UGT2B17—prostate cancer	1.6e-05	0.000246	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CKMT2—prostate cancer	1.6e-05	0.000246	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—UGT2B15—prostate cancer	1.6e-05	0.000246	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GRHPR—prostate cancer	1.6e-05	0.000246	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—NCOA1—prostate cancer	1.6e-05	0.000245	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MAP2K1—prostate cancer	1.58e-05	0.000243	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	1.58e-05	0.000242	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—LDHB—prostate cancer	1.57e-05	0.000241	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PIK3CD—prostate cancer	1.57e-05	0.000241	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—PIK3CA—prostate cancer	1.56e-05	0.000239	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—SERPINE1—prostate cancer	1.55e-05	0.000239	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP3A5—prostate cancer	1.54e-05	0.000237	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—KRAS—prostate cancer	1.54e-05	0.000236	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	1.54e-05	0.000236	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—RXRA—prostate cancer	1.52e-05	0.000233	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—FGF2—prostate cancer	1.51e-05	0.000231	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SULT2B1—prostate cancer	1.5e-05	0.000231	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—AOX1—prostate cancer	1.5e-05	0.000231	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—RFK—prostate cancer	1.5e-05	0.000231	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PGAM2—prostate cancer	1.5e-05	0.000231	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—MBTPS1—prostate cancer	1.5e-05	0.000231	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NAGLU—prostate cancer	1.5e-05	0.000231	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTM3—prostate cancer	1.5e-05	0.000231	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	1.5e-05	0.00023	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PDHA1—prostate cancer	1.49e-05	0.000229	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—UCP3—prostate cancer	1.49e-05	0.000229	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GSTA3—prostate cancer	1.49e-05	0.000229	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—TCN2—prostate cancer	1.49e-05	0.000229	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NOS3—prostate cancer	1.48e-05	0.000228	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—JAK2—prostate cancer	1.44e-05	0.000221	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—AMACR—prostate cancer	1.43e-05	0.000219	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP3A43—prostate cancer	1.43e-05	0.000219	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NAT1—prostate cancer	1.43e-05	0.000219	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—DEGS1—prostate cancer	1.43e-05	0.000219	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SRD5A2—prostate cancer	1.43e-05	0.000219	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—HSD3B1—prostate cancer	1.42e-05	0.000218	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SLC22A3—prostate cancer	1.42e-05	0.000218	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—PIK3CA—prostate cancer	1.41e-05	0.000217	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MDM2—prostate cancer	1.41e-05	0.000216	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—ERBB2—prostate cancer	1.39e-05	0.000213	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	1.38e-05	0.000211	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	1.37e-05	0.000211	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PIK3CB—prostate cancer	1.37e-05	0.00021	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GSTA4—prostate cancer	1.36e-05	0.000209	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—TBXAS1—prostate cancer	1.36e-05	0.000209	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HSD17B1—prostate cancer	1.36e-05	0.000209	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	1.35e-05	0.000207	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GSTA2—prostate cancer	1.33e-05	0.000204	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CXCL8—prostate cancer	1.32e-05	0.000202	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SULT1A1—prostate cancer	1.31e-05	0.000202	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ABCG5—prostate cancer	1.31e-05	0.000202	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CDKN1B—prostate cancer	1.29e-05	0.000197	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GSTA1—prostate cancer	1.28e-05	0.000197	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—AKT1—prostate cancer	1.27e-05	0.000195	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	1.27e-05	0.000195	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GSTO1—prostate cancer	1.27e-05	0.000195	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—HSD3B2—prostate cancer	1.27e-05	0.000195	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NAT2—prostate cancer	1.27e-05	0.000195	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CASP3—prostate cancer	1.26e-05	0.000193	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IL2—prostate cancer	1.26e-05	0.000193	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—IL6—prostate cancer	1.25e-05	0.000192	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CCND1—prostate cancer	1.23e-05	0.000188	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PLCB2—prostate cancer	1.22e-05	0.000187	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—LRP2—prostate cancer	1.22e-05	0.000187	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP2C18—prostate cancer	1.22e-05	0.000187	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CTNNB1—prostate cancer	1.21e-05	0.000186	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—B4GALT4—prostate cancer	1.21e-05	0.000186	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HPGD—prostate cancer	1.21e-05	0.000186	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—P4HB—prostate cancer	1.19e-05	0.000183	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MMP9—prostate cancer	1.19e-05	0.000183	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CDKN1A—prostate cancer	1.19e-05	0.000182	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PTEN—prostate cancer	1.18e-05	0.000182	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	1.17e-05	0.000179	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SLC22A1—prostate cancer	1.16e-05	0.000178	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—PPARA—prostate cancer	1.16e-05	0.000178	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—AKT1—prostate cancer	1.16e-05	0.000177	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—TNFRSF21—prostate cancer	1.14e-05	0.000175	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SULT2A1—prostate cancer	1.13e-05	0.000173	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	1.13e-05	0.000173	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—EP300—prostate cancer	1.13e-05	0.000173	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—MED12—prostate cancer	1.11e-05	0.000171	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—MTAP—prostate cancer	1.11e-05	0.00017	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP7B1—prostate cancer	1.11e-05	0.00017	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GNG5—prostate cancer	1.1e-05	0.000169	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—SRC—prostate cancer	1.1e-05	0.000169	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SULT1E1—prostate cancer	1.08e-05	0.000166	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SRD5A1—prostate cancer	1.08e-05	0.000166	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—VEGFA—prostate cancer	1.07e-05	0.000164	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NCOA3—prostate cancer	1.06e-05	0.000163	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—STAT3—prostate cancer	1.06e-05	0.000163	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ACSL4—prostate cancer	1.03e-05	0.000158	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HSD17B3—prostate cancer	1.03e-05	0.000158	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—HPGDS—prostate cancer	1.01e-05	0.000156	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP2C19—prostate cancer	1.01e-05	0.000155	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PHGDH—prostate cancer	9.88e-06	0.000152	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—UMPS—prostate cancer	9.88e-06	0.000152	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ARG2—prostate cancer	9.88e-06	0.000152	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MYC—prostate cancer	9.84e-06	0.000151	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GSTT1—prostate cancer	9.83e-06	0.000151	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ACHE—prostate cancer	9.83e-06	0.000151	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—TGFB1—prostate cancer	9.82e-06	0.000151	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP2A6—prostate cancer	9.72e-06	0.000149	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—LDHB—prostate cancer	9.69e-06	0.000149	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—EGFR—prostate cancer	9.62e-06	0.000148	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	9.54e-06	0.000146	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP3A5—prostate cancer	9.51e-06	0.000146	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—AKR1C3—prostate cancer	9.46e-06	0.000145	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PRKACB—prostate cancer	9.41e-06	0.000144	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP17A1—prostate cancer	9.31e-06	0.000143	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	9.21e-06	0.000141	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PDHA1—prostate cancer	9.19e-06	0.000141	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTA3—prostate cancer	9.19e-06	0.000141	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—TCN2—prostate cancer	9.19e-06	0.000141	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—UCP3—prostate cancer	9.19e-06	0.000141	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—KRAS—prostate cancer	9.09e-06	0.00014	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NCOA2—prostate cancer	8.87e-06	0.000136	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HSD3B1—prostate cancer	8.77e-06	0.000135	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SLC22A3—prostate cancer	8.77e-06	0.000135	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SLC5A5—prostate cancer	8.46e-06	0.00013	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—TBXAS1—prostate cancer	8.4e-06	0.000129	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTA4—prostate cancer	8.4e-06	0.000129	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PIK3CA—prostate cancer	8.35e-06	0.000128	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP2E1—prostate cancer	8.26e-06	0.000127	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTA2—prostate cancer	8.19e-06	0.000126	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NQO1—prostate cancer	8.17e-06	0.000125	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SULT1A1—prostate cancer	8.09e-06	0.000124	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ABCG5—prostate cancer	8.09e-06	0.000124	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—TP53—prostate cancer	8.08e-06	0.000124	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—TH—prostate cancer	8.05e-06	0.000124	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP3A4—prostate cancer	7.97e-06	0.000122	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTA1—prostate cancer	7.9e-06	0.000121	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP1B1—prostate cancer	7.84e-06	0.00012	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HSD3B2—prostate cancer	7.81e-06	0.00012	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTO1—prostate cancer	7.81e-06	0.00012	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NAT2—prostate cancer	7.81e-06	0.00012	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GGT1—prostate cancer	7.59e-06	0.000116	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PLCB2—prostate cancer	7.49e-06	0.000115	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP2C18—prostate cancer	7.49e-06	0.000115	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—LRP2—prostate cancer	7.49e-06	0.000115	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NCOA1—prostate cancer	7.47e-06	0.000115	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IL6—prostate cancer	7.4e-06	0.000114	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP19A1—prostate cancer	7.37e-06	0.000113	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—P4HB—prostate cancer	7.35e-06	0.000113	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SLC22A1—prostate cancer	7.15e-06	0.00011	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—RXRA—prostate cancer	7.11e-06	0.000109	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SULT2A1—prostate cancer	6.96e-06	0.000107	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—MED12—prostate cancer	6.85e-06	0.000105	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—COMT—prostate cancer	6.85e-06	0.000105	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—AKT1—prostate cancer	6.82e-06	0.000105	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GSTP1—prostate cancer	6.82e-06	0.000105	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GNG5—prostate cancer	6.8e-06	0.000104	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ITPR1—prostate cancer	6.71e-06	0.000103	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NCOA3—prostate cancer	6.55e-06	0.0001	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—TYMS—prostate cancer	6.34e-06	9.73e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GSTM1—prostate cancer	6.26e-06	9.61e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HPGDS—prostate cancer	6.25e-06	9.59e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP2C19—prostate cancer	6.21e-06	9.53e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—LPL—prostate cancer	6.15e-06	9.44e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ACHE—prostate cancer	6.06e-06	9.3e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTT1—prostate cancer	6.06e-06	9.3e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP2A6—prostate cancer	5.99e-06	9.19e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP1A1—prostate cancer	5.94e-06	9.11e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ERCC2—prostate cancer	5.89e-06	9.04e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—AKR1C3—prostate cancer	5.83e-06	8.94e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PRKACB—prostate cancer	5.79e-06	8.89e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP17A1—prostate cancer	5.73e-06	8.8e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—MTHFR—prostate cancer	5.54e-06	8.5e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NCOA2—prostate cancer	5.46e-06	8.39e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PPARA—prostate cancer	5.43e-06	8.34e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SLC5A5—prostate cancer	5.21e-06	8e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CAV1—prostate cancer	5.11e-06	7.84e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP2E1—prostate cancer	5.09e-06	7.82e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NQO1—prostate cancer	5.03e-06	7.73e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—TH—prostate cancer	4.96e-06	7.62e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP1B1—prostate cancer	4.83e-06	7.41e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GGT1—prostate cancer	4.68e-06	7.18e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PIK3CG—prostate cancer	4.65e-06	7.14e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NCOA1—prostate cancer	4.61e-06	7.07e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP19A1—prostate cancer	4.54e-06	6.97e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—INS—prostate cancer	4.4e-06	6.76e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—RXRA—prostate cancer	4.38e-06	6.72e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CREBBP—prostate cancer	4.31e-06	6.62e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—COMT—prostate cancer	4.22e-06	6.48e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTP1—prostate cancer	4.2e-06	6.45e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ITPR1—prostate cancer	4.13e-06	6.34e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PIK3CD—prostate cancer	4.09e-06	6.28e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—TYMS—prostate cancer	3.9e-06	5.99e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NOS3—prostate cancer	3.86e-06	5.93e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTM1—prostate cancer	3.86e-06	5.92e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—LPL—prostate cancer	3.79e-06	5.81e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP1A1—prostate cancer	3.66e-06	5.62e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ERCC2—prostate cancer	3.63e-06	5.57e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PIK3CB—prostate cancer	3.56e-06	5.47e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PTGS2—prostate cancer	3.53e-06	5.42e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—MTHFR—prostate cancer	3.41e-06	5.23e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PPARA—prostate cancer	3.35e-06	5.14e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CAV1—prostate cancer	3.15e-06	4.83e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PTEN—prostate cancer	3.08e-06	4.73e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—EP300—prostate cancer	2.94e-06	4.51e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PIK3CG—prostate cancer	2.87e-06	4.4e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—INS—prostate cancer	2.71e-06	4.16e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CREBBP—prostate cancer	2.66e-06	4.08e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PIK3CD—prostate cancer	2.52e-06	3.87e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NOS3—prostate cancer	2.38e-06	3.65e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PIK3CB—prostate cancer	2.2e-06	3.37e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PTGS2—prostate cancer	2.18e-06	3.34e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PIK3CA—prostate cancer	2.17e-06	3.33e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PTEN—prostate cancer	1.9e-06	2.91e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—EP300—prostate cancer	1.81e-06	2.78e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—AKT1—prostate cancer	1.77e-06	2.72e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.34e-06	2.05e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—AKT1—prostate cancer	1.09e-06	1.68e-05	CbGpPWpGaD
